Atlas Trials

Evaluation of Safety and Pharmacokinetics of Oral Controlled-ileal-release Nicotinic Acid (CIR-NA) Compared to Immediate-release Nicotinic Acid and Placebo in Healthy Subjects and Subjects With Prediabetes

Clinical trial NCT06378125 · COMPLETED

Trial details

NCT number
NCT06378125
Sponsor
University Hospital Schleswig-Holstein
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Safety IssuesPharmacokinetic
Start date
2022-12-19
Primary completion
2024-11-12
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.